Literature DB >> 29622669

Secular Trends in Infection-Related Mortality after Kidney Transplantation.

Susanna Kinnunen1, Pauli Karhapää1, Auni Juutilainen1, Patrik Finne2,3, Ilkka Helanterä4.   

Abstract

BACKGROUND AND OBJECTIVES: Infections are the most common noncardiovascular causes of death after kidney transplantation. We analyzed the current infection-related mortality among kidney transplant recipients in a nationwide cohort in Finland. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Altogether, 3249 adult recipients of a first kidney transplant from 1990 to 2012 were included. Infectious causes of death were analyzed, and the mortality rates for infections were compared between two eras (1990-1999 and 2000-2012). Risk factors for infectious deaths were analyzed with Cox regression and competing risk analyses.
RESULTS: Altogether, 953 patients (29%) died during the follow-up, with 204 infection-related deaths. Mortality rate (per 1000 patient-years) due to infections was lower in the more recent cohort (4.6; 95% confidence interval, 3.5 to 6.1) compared with the older cohort (9.1; 95% confidence interval, 7.6 to 10.7); the incidence rate ratio of infectious mortality was 0.51 (95% confidence interval, 0.30 to 0.68). The main causes of infectious deaths were common bacterial infections: septicemia in 38% and pulmonary infections in 45%. Viral and fungal infections caused only 2% and 3% of infectious deaths, respectively (such as individual patients with Cytomegalovirus pneumonia, Herpes simplex virus meningoencephalitis, Varicella zoster virus encephalitis, and Pneumocystis jirovecii infection). Similarly, opportunistic bacterial infections rarely caused death; only one death was caused by Listeria monocytogenes, and two were caused by Mycobacterium tuberculosis. Only 23 (11%) of infection-related deaths occurred during the first post-transplant year. Older recipient age, higher plasma creatinine concentration at the end of the first post-transplant year, diabetes as a cause of ESKD, longer pretransplant dialysis duration, acute rejection, low albumin level, and earlier era of transplantation were associated with increased risk of infectious death in multivariable analysis.
CONCLUSIONS: The risk of death due to infectious causes after kidney transplantation in Finland dropped by one half since the 1990s. Common bacterial infections remained the most frequent cause of infection-related mortality, whereas opportunistic viral, fungal, or unconventional bacterial infections rarely caused deaths after kidney transplantation.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  Albumins; Bacterial Infections; Cause of Death; Encephalitis; Finland; Follow-Up Studies; Fungal Viruses; Herpesvirus 3, Human; Incidence; Kidney Failure, Chronic; Listeria monocytogenes; Meningoencephalitis; Mycobacterium tuberculosis; Mycoses; Pneumocystis carinii; Pneumonia; Sepsis; Simplexvirus; creatinine; cytomegalovirus; diabetes mellitus; infections; kidney transplantation; mortality risk; risk factors

Mesh:

Year:  2018        PMID: 29622669      PMCID: PMC5969482          DOI: 10.2215/CJN.11511017

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  27 in total

1.  Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS.

Authors:  Vikas R Dharnidharka; Donald M Stablein; William E Harmon
Journal:  Am J Transplant       Date:  2004-03       Impact factor: 8.086

2.  When do we need competing risks methods for survival analysis in nephrology?

Authors:  Marlies Noordzij; Karen Leffondré; Karlijn J van Stralen; Carmine Zoccali; Friedo W Dekker; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2013-08-24       Impact factor: 5.992

3.  Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry.

Authors:  Judith L Vogelzang; Karlijn J van Stralen; Marlies Noordzij; Jose Abad Diez; Juan J Carrero; Cecile Couchoud; Friedo W Dekker; Patrik Finne; Denis Fouque; James G Heaf; Andries Hoitsma; Torbjørn Leivestad; Johan de Meester; Wendy Metcalfe; Runolfur Palsson; Maurizio Postorino; Pietro Ravani; Raymond Vanholder; Manfred Wallner; Christoph Wanner; Jaap W Groothoff; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2015-01-29       Impact factor: 5.992

4.  Outbreak of Influenza A(H1N1) in a Kidney Transplant Unit-Protective Effect of Vaccination.

Authors:  I Helanterä; V-J Anttila; M Lappalainen; M Lempinen; H Isoniemi
Journal:  Am J Transplant       Date:  2015-05-05       Impact factor: 8.086

5.  Epidemiology of sepsis in Germany: results from a national prospective multicenter study.

Authors:  Christoph Engel; Frank M Brunkhorst; Hans-Georg Bone; Reinhard Brunkhorst; Herwig Gerlach; Stefan Grond; Matthias Gruendling; Guenter Huhle; Ulrich Jaschinski; Stefan John; Konstantin Mayer; Michael Oppert; Derk Olthoff; Michael Quintel; Max Ragaller; Rolf Rossaint; Frank Stuber; Norbert Weiler; Tobias Welte; Holger Bogatsch; Christiane Hartog; Markus Loeffler; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2007-02-24       Impact factor: 17.440

6.  Mortality caused by sepsis in patients with end-stage renal disease compared with the general population.

Authors:  M J Sarnak; B L Jaber
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

Review 7.  Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

Authors:  Elisabeth M Hodson; Maleeka Ladhani; Angela C Webster; Giovanni F M Strippoli; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

8.  Current characteristics and outcome of cytomegalovirus infections after kidney transplantation.

Authors:  I Helanterä; T Schachtner; C Hinrichs; K Salmela; L Kyllönen; P Koskinen; I Lautenschlager; P Reinke
Journal:  Transpl Infect Dis       Date:  2014-06-26       Impact factor: 2.228

9.  The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry.

Authors:  Maria Pippias; Kitty J Jager; Anneke Kramer; Torbjørn Leivestad; Manuel Benítez Sánchez; Fergus J Caskey; Frederic Collart; Cécile Couchoud; Friedo W Dekker; Patrik Finne; Denis Fouque; James G Heaf; Marc H Hemmelder; Reinhard Kramar; Johan De Meester; Marlies Noordzij; Runolfur Palsson; Julio Pascual; Oscar Zurriaga; Christoph Wanner; Vianda S Stel
Journal:  Nephrol Dial Transplant       Date:  2015-09-11       Impact factor: 5.992

Review 10.  Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes.

Authors:  Andrew F Shorr; Gregory M Susla; Naomi P O'Grady
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

View more
  25 in total

1.  Antibiotic therapy in case of positive cultures of kidney transplant preservation fluid: a nationwide survey of prescribing practices.

Authors:  N Le Berre; M Ladrière; A Corbel; T Remen; L Durin; L Frimat; N Thilly; C Pulcini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-04       Impact factor: 3.267

2.  Death after Kidney Transplantation: An Analysis by Era and Time Post-Transplant.

Authors:  Tracey Ying; Bree Shi; Patrick J Kelly; Helen Pilmore; Philip A Clayton; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2020-09-09       Impact factor: 10.121

3.  Infection-Related Mortality in Recipients of a Kidney Transplant in Australia and New Zealand.

Authors:  Samuel Chan; Elaine M Pascoe; Philip A Clayton; Stephen P McDonald; Wai H Lim; Matthew P Sypek; Suetonia C Palmer; Nicole M Isbel; Ross S Francis; Scott B Campbell; Carmel M Hawley; David W Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2019-08-27       Impact factor: 8.237

4.  Oral/oesophageal candidiasis is a risk factor for severe infection after kidney transplantation.

Authors:  Tetsuya Abe; Kenta Futamura; Norihiko Goto; Kiyomi Ohara; Taiki Ogasa; Toshihide Tomosugi; Manabu Okada; Takahisa Hiramitsu; Shunji Narumi; Yoshihiko Watarai
Journal:  Nephrology (Carlton)       Date:  2021-08-21       Impact factor: 2.358

5.  Effect of pretransplant dialysis vintage on clinical outcomes in deceased donor kidney transplant.

Authors:  Jeong-Hoon Lim; Yena Jeon; Deok Gie Kim; Yeong Hoon Kim; Joong Kyung Kim; Jaeseok Yang; Myoung Soo Kim; Hee-Yeon Jung; Ji-Young Choi; Sun-Hee Park; Chan-Duck Kim; Yong-Lim Kim; Jang-Hee Cho
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

6.  Single-center analysis of infectious complications in older adults during the first year after kidney transplantation.

Authors:  Marion Hemmersbach-Miller; Barbara D Alexander; Debra L Sudan; Carl Pieper; Kenneth E Schmader
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-10-23       Impact factor: 3.267

7.  Machine learning for the prediction of severe pneumonia during posttransplant hospitalization in recipients of a deceased-donor kidney transplant.

Authors:  You Luo; Zuofu Tang; Xiao Hu; Shuo Lu; Bin Miao; Songlin Hong; Haiyun Bai; Chen Sun; Jiang Qiu; Huiying Liang; Ning Na
Journal:  Ann Transl Med       Date:  2020-02

8.  Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives.

Authors:  Davide Fiore Bavaro; Alessandra Belati; Lucia Diella; Monica Stufano; Federica Romanelli; Luca Scalone; Stefania Stolfa; Luigi Ronga; Leonarda Maurmo; Maria Dell'Aera; Adriana Mosca; Lidia Dalfino; Salvatore Grasso; Annalisa Saracino
Journal:  Antibiotics (Basel)       Date:  2021-05-29

9.  Incidence Rate of Post-Kidney Transplant Infection: A Retrospective Cohort Study Examining Infection Rates at a Large Canadian Multicenter Tertiary-Care Facility.

Authors:  Juthaporn Cowan; Alexandria Bennett; Nicholas Fergusson; Cheynne McLean; Ranjeeta Mallick; D William Cameron; Greg Knoll
Journal:  Can J Kidney Health Dis       Date:  2018-09-12

Review 10.  Overview on urinary tract infection, bacterial agents, and antibiotic resistance pattern in renal transplant recipients.

Authors:  Xiuchun Zhang; Hui Gao; Juan Fu; Feng Lin; Azad Khaledi
Journal:  J Res Med Sci       Date:  2021-03-31       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.